STEVANATO GROUP SPA O.N. (87N) - Total Liabilities
Based on the latest financial reports, STEVANATO GROUP SPA O.N. (87N) has total liabilities worth €1.07 Billion EUR (≈ $1.25 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore STEVANATO GROUP SPA O.N. (87N) investment intensity to see how much of total assets are deployed in long-term investments.
STEVANATO GROUP SPA O.N. - Total Liabilities Trend (2021–2025)
This chart illustrates how STEVANATO GROUP SPA O.N.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of STEVANATO GROUP SPA O.N..
STEVANATO GROUP SPA O.N. Competitors by Total Liabilities
The table below lists competitors of STEVANATO GROUP SPA O.N. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ARB Corporation Ltd
AU:ARB
|
Australia | AU$134.90 Million |
|
Hunan Changgao High Voltage Switchgear Group Co Ltd
SHE:002452
|
China | CN¥1.73 Billion |
|
Huludao Zinc Industry Co Ltd
SHE:000751
|
China | CN¥7.34 Billion |
|
CERES POWER HLDGS
F:CFJ
|
Germany | €38.15 Million |
|
Cangzhou Mingzhu Plastic Co Ltd
SHE:002108
|
China | CN¥3.33 Billion |
|
eXp World Holdings Inc
NASDAQ:EXPI
|
USA | $223.48 Million |
|
Max Estates Limited
NSE:MAXESTATES
|
India | Rs92.76 Billion |
|
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS
IS:ECILC
|
Turkey | TL13.28 Billion |
Liability Composition Analysis (2021–2025)
This chart breaks down STEVANATO GROUP SPA O.N.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See STEVANATO GROUP SPA O.N. net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.61 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.69 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how STEVANATO GROUP SPA O.N.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for STEVANATO GROUP SPA O.N. (2021–2025)
The table below shows the annual total liabilities of STEVANATO GROUP SPA O.N. from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €1.06 Billion ≈ $1.24 Billion |
+14.39% |
| 2024-12-31 | €924.43 Million ≈ $1.08 Billion |
-1.54% |
| 2023-12-31 | €938.93 Million ≈ $1.10 Billion |
+41.45% |
| 2022-12-31 | €663.79 Million ≈ $776.04 Million |
+15.00% |
| 2021-12-31 | €577.18 Million ≈ $674.79 Million |
-- |
About STEVANATO GROUP SPA O.N.
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprisi… Read more